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ABSTRACT
Monita Sharma Ph.D., Biomedical Sciences Ph.D. Program, Department of Pharmcology
and Toxicology, Wright State University, 2013. Simulating hemodynamics in in vitro
models: Implications on nano-biointeractions.

Gold nanoparticles (Au-NPs) have demonstrated great potential in the
development of a variety of tools with applications ranging from biomedical to military
fields. Consequently, there is increasing concern regarding the toxic potential of these
nanomaterials. Biodistribution studies demonstrate clearance of Au-NPs from peripheral
circulation and bulk localization primarily in the liver and spleen post- intravenous
administration. Deposition of Au-NPs in spleen suggests the potential for direct exposure
of immune cells to these foreign materials under relatively static conditions. Although
much less, due to the Blood Brain Barrier (BBB), Au-NPs appear to also deposit in the
brain, suggesting that the resident cells of the brain may also be exposed to Au-NPs.
Studies show the toxic potential of Au-NPs in a variety of cell types, however, the overall
picture is still inconclusive due to the variation in cell-to-cell responses to these NPs.
Additionally, NP aggregation and sedimentation in static in vitro conditions makes it very
difficult to achieve uniformly dispersed treatment solutions. Furthermore, static
conditions might be physiologically relevant to certain cell types, such as the immune
cells in the spleen and lymph nodes; however the ‘BBB’ experiences continuous flow of
blood. Therefore, NP research calls for modification of traditional in vitro models to
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simulate the in vivo conditions. The main aim of this study was to determine the impact
of Au-NPs on two model systems; 1) a B-lymphocyte cell line (CH12.LX) which pose as
a direct target to NPs in vivo and 2) a co-culture of an astrocytic (C8-D30) and an
endothelial cell line (bEnd.3), where endothelial cells shield the astrocytic cell line from
direct exposure to NPs. Furthermore, static conditions might be physiologically relevant
to certain cell types, such as the immune cells in the spleen and lymph nodes; however
the ‘BBB’ experiences continuous flow of blood. Our results demonstrate that treatment
with Au-NPs lead to altered B-cell function, in terms of increased antibody expression,
but no change in astrocytic and endothelial cell function was observed in terms of the
inflammatory cytokine release. This might suggest that Au-NPs might exhibit differential
response in different cell types which further emphasizes the need of careful evaluation
of NPs before in vivo use. Furthermore, we observed decrease in agglomeration and
deposition under flow conditions in comparison to static in vitro conditions suggesting
improvement of traditional in vitro models to simulate the in vivo conditions.
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I. BACKGROUND
Gold Nanoparticles: Properties and Applications
Nanoparticles have found a niche in every area of advanced science leading to
emergence of interdisciplinary fields such as nanophysics, nanochemistry, nanomedicine.
Gold nanoparticles (Au-NPs) possess a plethora of unique physiochemical properties that
have lead to their use in almost every field of science. These properties make them well
suited for applications as sensors, catalysts, photothermal, photoacoustic, photodynamic
and radio therapy (Jain et al., 2008, Liu and Ye, 2013, Boisselier and Astruc, 2009). The
unique characteristics of nanogold are dependent on its size, shape, charge,
functionalization, roughness and surface area (Tang and Cheng, 2013, Guler and Turan,
2010). In addition to the above mentioned properties, the ease of coupling Au-NPs with a
variety of materials including biomolecules has opened a whole realm of possibilities for
developing nanosized tools. Fig 1 summarizes some of the unique properties of Au-NPs
and their respective applications (Sharma et al., 2006, Lisa et al., 2009, Kho, 2007,
Huang, 2006, Hakkinen, 2012, Gang, 2009, Jain et al., 2008). These include sensors with
greater detection capabilities and biological assays with rapid and precise results.
Like other metallic NPs, Au-NPs possess unique surface plasmon resonance (SPR)
property, which is the ability of NPs to scatter light at a particular wavelength depending
on their size, morphology, functionalization and immediate environment. This particular
property of Au-NPs has been exploited in sensor based applications to detect a number of
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Fig 1: Unique properties of Au-NPs and their potential applications
Depicted are some of the properties of Au-NPs that have been exploited in a variety of
applications.
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Fig. 1
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biological and chemical analytes (Bai, 2007, Du et al., 2007, Lan et al., 2008, Lisa et al.,
2009, Lisha and Pradeep, 2009).
The shift in SPR of NPs has lead to development of new bio-assays in addition to
increase in sensitivity of already existing assays such as enzyme linked immuno-sorbent
assay (ELISA) (de la Rica and Stevens, 2012). Identification followed by detection of
cancer markers in the biological fluids (serum, saliva) is very important in order to
evaluate the disease diagnosis and progression. SPR coupled to the ability of Au-NPs to
convert light into thermal energy has extended their use in cancer therapy as
photothermal agents (Curley et al., 2008, Abdulla-Al-Mamun et al., 2009, Elliott, 2007,
Maksimova et al., 2007, El-Sayed, 2006). Additionally, the amperometric property of
Au-NPs make them ideal for development of nanocatalysts (Chen, 2006, Cui, 2011,
Kokoh, 2006, Li, 2008, Mertens, 2005).
Specific and targeted applications usually require functionalization of Au-NPs
with specific molecules. The most commonly used method of attaching biological or
chemical moieties to Au-NPs is to tag the former with a –thiol group (-SH) or amine (NH2) and then incubating them with Au-NPs (Hakkinen, 2012, Ungureanu et al., 2010,
Krishna et al., 2011). Like Au compounds, Au-NPs have inherent affinity for –SH and
this chemical interaction has been extensively used to tag Au-NPs with various functional
groups depending on the required application. The extent of Au specificity for –SH is
reflected by studies that show –SH containing proteins can be selectively separated from
a mixture using Au-NPs (Mizukoshi, 2006, Wang and Yang, 2010). Antibody-tagged AuNPs are used as a targeted approach to detect and treat pathological conditions such as
cancer (Kho, 2007, Aydogan, 2010, Srivalleesha et al., 2009, Tang et al., 2006, Visaria et
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al., 2007, Gang, 2009). The ability to control and target nanomaterials to the location of
interest has lead to the use of Au-NPs as drug carriers, gene therapy and gene delivery
agents (Xu et al., 2006, Asadishad et al., 2010, Aghdam et al., 2008).
Nanoparticle Characterization
Prior to their use in specific applications, NPs need to be extensively evaluated
(characterized). The importance of knowing the exact specifics of nanomaterials lies in
the fact that the applications and biointeraction of nanomaterials are dependent on their
size, shape, surface charge, concentration, composition, and agglomeration patterns.
Thorough characterization generates the information regarding the physiochemical
properties of nanomaterials, which is absolutely important in conducting further studies.
Characterization techniques are common among almost all kinds of nanomaterials. These
techniques exploit the specific material properties of nanoparticles to identify and assign
dimensions to the nanomaterials. For primary particle size and shape, transmission
electron microscopy (TEM) and atomic force microscopy (AFM) are generally used.
Dynamic light scattering (DLS) provides the particle size and charge in solution (Chicea,
2010, Murphy et al., 2010, Richard et al., 2008). DLS is also used to determine the
aggregate sizes of NPs in a variety of bio-chemical solutions. Elemental composition and
quantification of NPs is done by using inductively coupled plasma-mass spectrometry
[ICP-MS] (Zhen et al., 2007, Scheffer et al., 2008). With the realization of the extensive
applications of NPs, the aforementioned techniques have become standard for
nanomaterial characterization in NP research.
In order to understand NP interaction with intracellular biomolecules it is
important to visualize their localization in the cells. The mode of uptake of these foreign
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materials is based on their size, shape, functionalization, treatment conditions, and
location in the body and cell type. Uptake and interaction of NPs with cells is evaluated
using fluorescence based imaging techniques and TEM. Additionally, incubation of NPs
with protein rich environment leads to adsorption of proteins on the NP surface referred
to as ‘protein corona’ (Arvizo, 2012, Martin et al., 2008, Nel, 2009). To determine the
potential protein interactions with Au-NPs, techniques such as Western Blotting, Mass
spectrometry, Raman spectroscopy and Zeta potential are used. There are many more
techniques being developed to answer the gaps that exist for proper nanoparticle
characterization as well as their interactions with cells.
Nanoparticle agglomeration in physiological fluids
Nanotoxicity assessment is typically carried out using traditional toxicological
techniques involving treatment of static in vitro cultures with the NP of interest and
assuming homogeneous dispersion of NPs in the treatment solution over an exposure
period. However, NPs have been shown to agglomerate in physiological fluids
presumably due to formation of protein corona, leading to uneven deposition of NP
aggregates on the cells. Protein corona appears to dictate the dynamics of NP interaction
with the cells as indicated by the decreased uptake of polyethylene-glycol coated NPs
because of negligible protein adsorption on their surface (Nimi et al., 2011, Safi et al.,
2011, Pitek et al., 2012, Larson et al., 2012). Realistically, the NPs are deposited onto the
cells through a combination of sedimentation (i.e. deposition due to the force of gravity
on an object with mass) and Brownian forces (i.e. deposition due to random Brownian
motion) (Teeguarden et al., 2007). For spherical NPs, the sedimentation force is a
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Fig 2: NPs adsorb proteins and aggregate in physiological fluids
NPs adsorb proteins (and other biomolecules) on their surface under physiological
conditions, often referred to as the ‘protein corona’. NP morphology and formation of
protein corona dictate the agglomeration of NPs. The NP agglomerates tend to sediment
in the bottom of the solution. The sedimentation of NP agglomerates depends on their
density which is calculated based on the volume fraction of NPs versus proteins in the
agglomerate and is referred to as the fractal dimension (DF). The higher the DF, higher is
the density of the agglomerate and greater is the sedimentation. NP solutions can be
characterized using dynamic light scattering which gives out the hydrodynamic diameter
(DH ) of NPs. Different sizes of the NPs and their agglomerates can have the same
hydrodynamic diameter based on the number of NPs (and protein corona) in the
agglomerate.
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Fig. 2
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function of both agglomerate size and density, while the Brownian force is a function of
the agglomerate size only (Eun et al., 2011, Hinderliter et al., 2010, Mason and Weaver,
1924). The density of a NP agglomerate is determined by the volume fraction of NPs
versus proteins and other adsorbed species, often referred to as fractal dimension (DF).
The fractal dimension is a dimensionless number from 1 to 3 that characterizes the
amount of space in the agglomerate composed of Au NPs versus filled with media. A DF
of 3 reflects a fractal structure with zero porosity and high apparent density and DF of 1
reflects a very porous fractal structure with lower density (Fig. 2). The density of the NPs
or their agglomerates dictates their sedimentation kinetics on the cell layer in in vitro
cultures. A recent study comparing cellular orientation (upright versus inverted) in an in
vitro culture suggested that NPs deposit onto cells by Brownian force only in an inverted
orientation (Eun et al., 2011). Therefore, alternate approaches are required to reduce
challenges associated with sedimentation and produce uniform NP deposition to better
predict and correlate the treatment dose to response. As technology progresses, we might
be able to understand the interactions of nanomaterials with the cellular environment
which could further our knowledge of NP physiochemistry and their potential
applications in innumerable fields.
Toxicity of Au-NPs
The list of Au-NP applications is ever growing due to their relative inertness and
lack of overt toxicity towards biological systems. However, the use of Au-NPs as
catalysts indicates their capability to interfere with biochemical reactions. Further proof
of the non-inert nature of Au-NPs comes from both in vitro and in vivo studies that
demonstrate toxicity and modulation of cell function by Au-NPs (Khlebtsov and
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Dykman, 2011, Lasagna-Reeves et al., 2010, Kunzmann et al., 2011, Schaeublin, 2012,
Abdelhalim and Jarrar, 2011c, Abdelhalim and Jarrar, 2011b, Abdelhalim and Jarrar,
2011d). These studies range from evaluation of Au-NPs in biological media (cell culture
media, serum, blood) to intravenous injection in animal models. Table 1 summarizes
some of the studies that show toxic potential of Au-NPs. Despite these studies, there is
still a debate on whether or not Au-NPs could be safely used for in vivo applications. The
inconclusive nature of the toxic potential of Au-NPs likely stems from the variations in
the NP synthesis procedures, lack of thorough characterization, surface functionalization,
aggregation patterns and use of physiologically irrelevant dosages. Additionally,
differrential responses between different cell types to one kind of NPs leads to the
inability to generalize the mechanism of NP toxicity (Ekstrand-Hammarstrom et al.,
2011). Furthermore, size, charge and morphology seem to dictate the respective
biointeraction of these nanomaterials further emphasizing the need to carefully evaluate
(characterize) the nanomaterials before and after their interaction with biological and/or
chemical environments (Schaeublin, 2012, Pan, 2007).
Gold and immune cells
Gold compounds such as aurothiomalate

and auronofin have been used for

decades to treat pathological conditions such as rheumatoid arthritis (RA), inflammatory
airway and bowel diseases. These gold compounds effect function of a variety of
peripheral immune cells such as increase in prostaglandin E2 production by rat peritoneal
macrophages (Yamashita et al., 1997), JAK1/STAT3 mediated suppression of IL-6
secretion by human hepatoma cell line (Kim et al., 2007) , decrease in secretion of IL-6,
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Table1: Toxicity of citrate-stabilized Au-NPs
Listed are the studies conducted with citrate-stabilized Au-NPs that demonstrate toxicity
of these nanomaterials in a number of in vitro and in vivo model systems.
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IL-8 and TNF-α in human monocytic and synoviocytic cell lines (Kim et al., 2010).
Further evidence suggests that Au compounds inhibit the NF-κB pathway due to their
potential interaction with the cysteine residues on IKK leading to inactivation of IKK
complex (Jeon et al., 2000, Jue et al., 1999). Although, these studies show the potential
impact of Au in peripheral immune cells, fewer studies have analyzed their effects on
neuroimmune cells. Auronofin has been shown to cross the ‘blood Brain Barrier’ in a
mouse model (C57BL/6 mice), and

induce heme oxygenase -1 in primary human

astrocytes and U-373 MG cells (astrocytic cell line) with no effect on IL-6 and IL-8
secretion (Madeira et al., 2013). Although, these studies demonstrate the biological
impact of Au compounds, they might provide a starting point to mechanistically identify
the potential intracellular targets of Au-NPs.
The effects of nanomaterials on cell signaling such as NF-B activity are not
limited to that of Au-NPs. Carboxylated single-walled carbon nanotubes (1-2 nm
diameter, 5-30 (μm length) have been shown to induce NF-B nuclear localization and
binding to DNA in primary monocytes and lymphocytes (Ye et al., 2011).Titanium
dioxide NPs activate classical NF-B signaling in mouse liver (Ma et al., 2009).
Activation of NF-B has also been shown to be one of the outcomes post-exposure to
quantum dots, silica NPs and zinc oxide NPs in vitro (Liu and Sun, 2010, Romoser et al.,
2011, Tsou et al., 2010). Therefore, the NF-B signaling pathway may be a universal
target of nanomaterials. NF-B pathway is found in almost all the cells of the body and
orchestrates a number of cell, tissue and organ level responses (Hayden and Ghosh,
2012). Consequently, dysregulation of this pathway can have broad deleterious effects.
The NF-B pathway
18

NF-B derived its name from its function as a regulator of expression of the -B
light chain in B cells (nuclear factor kappa-light-chain-enhancer of activated B cells).
NF-B/Rel proteins represent a family of transcription factors that not only regulate
inflammatory responses but also the expression of a wide variety of genes encompassing
a spectrum of cellular activities such as proliferation, differentiation, and apoptosis
(Perkins, 2007, Vallabhapurapu and Karin, 2009). The NF-B family has five known
proteins: RelA (p65), RelB, cRel, NF-κB1 (p50), and NF-κB2 (p52), each of which may
form homo- or heterodimers which bind to κB enhancers of numerous target genes. In
absence of an inducing signal, NF-κB is sequestered in the cytoplasm through association
with its inhibitors: IκBα or p100 proteins. IκBα is an NF-κB inhibitor whereas p100 acts
as inhibitor and precursor of p52 subunit.
NF-κB is activated through at least three major receptor-mediated pathways,
‘canonical’ (or classical), ‘non-canonical’ (or atypical), or ‘alternate’ (Fig. 3). Cellular
kinases such as the Inhibitory B kinase (IKK) and NF-κB-inducing kinase (NIK) play an
important role in NF-κB activation via ‘canonical’ and ‘non-canonical’ pathways. The
IKK complex consists of two catalytic subunits (IKKα and IKKβ) and a regulatory
subunit (IKKγ). In the canonical pathway, activation of IKK by an inducing signal (e.g.
lipopolysaccharide) leads to phosphorylation of IκBα at serines 32 and 36 followed by
ubiquitination and proteosomal degradation of IκBα. IκBα degradation releases NF-κB
dimers (i.e. p50/RelA), which translocate to the nucleus and elicit initiation of gene
transcription (Beinke and Ley, 2004, Bonizzi and Karin, 2004, Hayden and Ghosh,
2008). The ‘Non-canonical’ pathway constitutes NIK-dependent activation of IKKα
subunits of the IKK complex which eventually leads to p100 phosphorylation and
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processing to generate p52 subunit as well as nuclear translocation of the RelB/p52
heterodimer, instead of degradation of IκBα (Sun, 2011, Dejardin, 2002, Senftleben,
2001). Alternatively, NF-κBs could be activated independent of IKK dependent
phosphorylation and ubiquitination of IκBα via tyrosine 42 phosphorylation on IκBα
protein (Livolsi, 2001, Fan et al., 2003). Once released from the inhibitory IκBs, NF-κB
dimers translocate to nucleus where they can bind the promoter and the enhancer regions
containing κB consensus sequences, 5ʹ GGGRNWYYCC 3ʹ (N-any base; R-purine; Wadenine or thymine; and Y-pyrimidine) leading to transcription initiation. NF-κB activity
is regulated at various levels via negative feedback mechanisms (Renner and Schmitz,
2009). These feedback loops usually involve proteins, such as IκBα that are produced in
response to NF-κB activation (Moss et al., 2012, Coornaert et al., 2009), however other
mechanisms have also been described.
Pathophysiological significance of NF-B pathway
With the involvement of NF-B proteins in a variety of cellular functions, its
aberrant activity has been shown to have detrimental effects. For instance, NF-B
inhibition in a p50/p52 double knockout mice impaired B-cell maturation (Franzoso,
1997). Similarly, persistent activation of NF-B is one of the hallmarks of inflammatory
airway and bowel diseases (Neurath et al., 1998, Tak and Firestein, 2001, Tsao, 1997).
Chronic activation of epithelial NF-B in a mouse model with constitutively active form
of IKKβ, lead to tumor initiation and upregulation of iNOS (Shaked, 2012). Activation of
hepatic NF-B in a mouse model with constitutively active IKK allele, caused macrophage-mediated chronic inflammation leading to liver fibrosis (Sunami, 2012).
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Fig 3: Activation of NF-κB (nuclear factor-κB) by ‘canonical’, ‘non-canonical’ and
‘alternate’ pathways.
In the canonical pathway, receptor mediated activation of IKK leads to phosphorylation
of IκBα (inhibitory protein) at serines 32 and 36 which promotes its ubiquitination and
degradation leading to nuclear translocation of p50/RelA. In ‘non-canonical’ pathway
NIK-dependent activation of IKKα induces processing of p100 to p52 resulting in nuclear
translocation of p52/RelB. Alternatively, IKK independent phosphorylation of IκBα at
tyrosine 42 residue leads to detachment of IκBα from the NF-κB dimers leading to
nuclear translocation of p50/RelA. In all of the aforementioned pathways, the free NF-κB
dimers bind to κB sites on the target genes leading to transcription initiation
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Fig. 3
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The detrimental effect of aberrant NF-B activity in a number of pathological conditions
has made it a primary drug target wherein specific inhibition/activation of this pathway
can directly impact disease progression. Inhibition of IKK, protected neurons against
damage caused by oxygen and nitrogen reactive species in a rat model for ischemicreperfusion cerebral damage (Desai et al., 2010). Inhibition of NF-B by minocycline
decreased the release of Beta-amyloid and reactive oxygen and nitrogen species in the
case of rat diabetes model (Cai et al., 2011).
NF-B pathway and B-cells
Biomedical applications of Au-NPs often involve intravenous administration
which leads to bulk localization of these NPs in liver and spleen. Being the largest
lymphoid organ, spleen plays a very important role in both adaptive and innate immune
responses. A number of immune cells inhabit spleen including B-cells, T-cells and
dendritic cells. Clearance of Au-NPs from peripheral circulation and their localization in
spleen suggests the potential exposure of B-cells, and other immune cells, to NPs in a
relatively static environment. B-lymphocytes, the main effector cells of humoral
immunity, secrete immunoglobulins (Ig) that bind antigens or invading pathogens and
non-self molecules with specificity and facilitate the clearance of these antigens from the
host. Antibody production is controlled by a functional interaction of several regulatory
elements such as promoters and enhancers on Ig Heavy (Igh) and light (IgL) chain
loci(Vincent-Fabert, 2010, Chauveau et al., 1998, Sen and Baltimore, 2006). Two
transcription enhancer regions, namely, Eμ intronic enhancer and 3ʹ regulatory region
(3ʹIgHRR) have been well studied in their role in B-cell maturation and function (Perlot
and Alt, 2008, Giannini et al., 1993, Ong et al., 1998, Chauveau et al., 1998).
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The 3ʹIgHRR constitutes four separate enhancers, hs3a, hs1, 2, hs3b and hs4
which collectively regulate IgH gene expression in plasma cells (Vincent-Fabert, 2010).
Within the 3ʹIgHRR there are DNA binding sites for transcription factors such as AP-1,
Oct and NF-κB (Michaelson et al., 1996, Sepulveda et al., 2004, Kanda et al., 2000).
Antibody production in B-lymphocytes may be partially mediated through NF-κB/Rel
binding to B motifs in the enhancer regions as demonstrated by reduction in secretion of
Ig in RelA deficient mice (Doi et al., 1997). Using an inducible mutant inhibitory κBα
(IκBα) superrepressor, Hsing and Bishop. 1999, further provided a proof for the role of
NF-B in antibody secretion by mouse B-cell lines (Hsing and Bishop, 1999). Since
previous studies demonstrate the potential for gold (compounds and nanoparticles) to
modulate NF-B activity, and there is evidence that the IgH gene expression might be
influenced by NF-B, Au-NPs might be capable of altering Ig secretion from B-cells.
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Fig 4: Mouse IgH gene locus.
Diagram of a mouse immunoglobulin heavy chain gene locus depicting the variable
heavy chain promoter (VH); VDJ – variable region defining antigen specificity; Eµ
intronic enhancer; open rectangles are the switch region for class switch recombination;
, 31, 2b, 2a,  are the heavy chain constant region isotypes producing IgM,
IgD, IgG3, IgG1, IgG2b, IgG2a, IgE, and IgA respectively and 3ʹ regulatory region
(3ʹIgHRR).
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Fig. 4

26

Role of astrocytes
Astrocytes belong to the group of glial cells in central nervous system (CNS)
called macroglia and considerably outnumber the neuronal cells (Dong and Benveniste,
2001). They are multifunctional cells, involved in maintaining the structural and
functional integrity of ‘BBB’ in addition to being capable of responding to various insults
to CNS (Dong and Benveniste, 2001, Cordiglieri and Farina, 2010). In response to injury
or infection, astrocytes go from a quiescent state to an activated state marked by
hypertrophy, increased expression of glial fibrillary acid protein (GFAP), and increased
proliferation, collectively referred to as astrogliosis. Astrogliosis is the term used to
indicate diseased CNS tissue and has been implicated in a number of pathological
conditions such as multiple schlerosis, alzheimers disease, toxoplasma encephalitis and
CNS injury (Kalishwaralal, 2011, Dehouck et al., 1990, Butt et al., 1990, Mironava,
2013, Zhang et al., 2009). The aforementioned disease states are also characterized by a
marked increase in the levels of a variety of cytokines and chemokines. The activated
astrocytes express cytokines (IL-1, IL-6, IL-10, IFN-α and β, GM-CSF, M-CSF, G-CSF,
TNF-α and TGF-β) and chemokines (RANTES, IL-8, monocyte chemoattractant protein1 and IP-10) (Dong and Benveniste, 2001, Burkert et al., 2012, Falsig et al., 2006,
Thompson and Van Eldik, 2009).However, the direct effect, of only a few cytokines has
been demonstrated. For instance, overexpression of TNF-α in astrocytes lead to
neurological disease in mice (Akassoglou et al., 1997). Additionally, TNF-α and IL-1
have been demonstrated to exacerbate ischaemic injury post-intracerebral injections in
vivo (Yamasaki et al., 1995, Barone et al., 1997). Peripheral infections such as bacterial
antigens and/or endotoxins are capable of inducing astrogliosis even without direct CNS
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infection. Microbes such as Herpes virus 1 can activate astrocytes leading to secretion of
interferons, IL-6 and serum amyloid A transcripts (Leifert, 2013). Furthermore, there is
evidence that gold (compounds and microsized particles) can cause activation of
astrocytes leading to upregulation of GFAP and metallothionein-1 and 2 in a mouse
experimental autoimmune encephalomyelitis model (Pedersen et al., 2012).
Astrogliosis can have both protective and detrimental effects. The protective role
of reactive astrocytes is demonstrated by the increase in leukocyte infiltration and
neuronal degeneration post-depletion of reactive astrocytes (Arvizo et al., 2011, Chen et
al., 2013). Furthermore, the activated astrocytes migrate to the site of injury and seclude
the inflammatory cells from the rest of the brain potentially facilitating recovery
(Dehouck et al., 1990, Arvizo et al., 2011, Butt et al., 1990). In contradiction to the
protective function of astrocytes, inhibition of astrogliosis can have therapeutic
applications. For instance, inhibition of NFAT mediated astrocyte activation in a mouse
model for Alzheimer’s Disease lead to improved cognitive and synaptic function (Begley
and Brightman, 2003).
NF-B pathway and Astrogliosis
NF-B has been shown to be essential for post-injury response in astrocytes as
indicated by reduced oxidative stress post-retinal ischemia-reperfusion injury in a mouse
model with genetically suppressed NF-B in astrocytes (Barakat et al., 2012). Inhibition
of NF-B using pyrrolidine dithiocarbamate in a mouse model for Alzheimer’s disease
(AD) lead to attenuation of astrogliosis as indicated by reduction in glial fibrillary acid
protein (GFAP). Direct activation of astrocytes by IL1β, TNFα and IFN-γ lead to NF-B
dependent secretion of chemokines such as, CCL2 and CCL7 (Thompson and Van Eldik,
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2009, Khorooshi et al., 2008, Kim, 2005, Kim et al., 2012). Since gold has been
demonstrated to cause activation of astrocytes leading to upregulation of GFAP and
metallothionein-1 and 2 in a mouse experimental autoimmune encephalomyelitis model
(Pedersen et al., 2012), and gold nanoparticles have been shown to cross the ‘BBB’ in a
number of studies (Morais, 2012, De Jong et al., 2008), it is critical to evaluate the impact
of Au-NPs in astrocytes and other resident cells of the brain.
Models to study ‘Blood Brain Barrier’
The selectivity of the ‘BBB’ towards the trafficking of molecules to the brain has
always posed limitations to delivering drugs to the different sites in the CNS. However,
biodistribution studies demonstrate limited accumulation of Au-NPs in the brain, (BBB)
(Dan et al., 2012, Lu et al., 2007, Sarin, 2008) therefore it is critical to evaluate the
response of astrocytes, and other cell types, to these foreign materials. The physiological
and molecular aspects of ‘BBB’ are usually studied in in vitro models comprising of the
brain endothelial cells co-cultured with astrocytes. Many versions of this cell
combination have been used previously to test trafficking of substrates across the ‘BBB’
(Naik and Cucullo, 2012, Töth et al., 2011, Grant et al., 1998, Garberg, 2005). Although,
these systems might be appropriate for studying transport of substrates that are water
soluble, they cannot be utilized to study NP trafficking across the ‘BBB’. The problem of
aggregation and sedimentation of NPs in biological media leads to uneven distribution
and uptake by cells in static conditions (Cho et al., 2011). Additionally, endothelial cells
are exposed to constant blood flow in in vivo conditions therefore dynamic in vitro
models are more relevant. Existing dynamic ‘BBB’ models take the aspect of
hemodynamics into consideration but the high cost and inability to analyze multiple
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biological endpoints are major drawbacks associated to them suggesting a need for
alternative approaches.
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II HYPOTHEISIS AND STRATEGIC AIMS
Hypothesis:
Au-NPs can induce functional dysregulation in murine B-cell (CH12.LX), endothelial
(bEnd.3) and astrocytic (C8-D30) cell lines.

Specific Aim 1: To determine if Au-NPs modulate cellular function in B-lymphocytes.

Specific Aim 2: To determine if Au-NPs impact endothelial and astrocytic function using
a dynamic multi-layered ‘Blood-Brain Barrier’ model.
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III CHAPTER 1: Au-NPS MODULATE NF-κB ACTIVITY AND CELLULAR
FUNCTION IN B-LYMPHOCYTES.
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SUMMARY
The sequestration of Au-NPs in the spleen makes B-cells, among other splenic
cells (T cells, dendritic cells), potential targets of these nanomaterials. Although, a
majority of toxicity studies favor the biocompatibility of Au-NPs, some studies have
demonstrated the potential of Au-NPs to modulate immune response. Significant
reduction in inflammation was observed after intradermal administration of citratestabilized 13 nm Au-NPs in Sprague-Dawley rats with collagen-induced arthritis (Tsai,
2007). Another study demonstrated a decrease in IL-12 secretion after treatment of
LPSstimulated dendritic cells (from C57BL/6 mice) with 13 mM of citrate-stabilized 10
nm Au-NPs (Villiers et al., 2010). Additionally, size dependent suppression of NF-κB
activity by Au-NPs (4, 11, 19, 35, 45 nm) in a macrophage cell line (Raw264.7) indicate
that Au-NPs might be capable of modulating immune cell function (Chiau-Yuang et al.,
2012). Since gold (compounds and NPs) has been shown to affect the NF-κB pathway,
and this transcription factor has been demonstrated to have potential effects on B-cell
function in terms of Ig production, we hypothesized that Au-NPs could lead to altered Bcell function.
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CELLULAR MODELS
We utilized CH12.LX cells, which is a murine B-cell line derived from a mature
B-cell lymphoma (Bishop and Haughton, 1986). CH12.LX cells have been used
previously to study physiological aspects of B-cell function such as activation and
differentiation in response to various stimuli (i.e. antigens and cytokines) (Kunimoto et
al., 1988, Kimura et al., 2000). CH12.LX cells have been used as a model to
mechanistically study the effects of environmental toxins such as TCDD and asbestos
which can be correlated to in vivo and ex vivo systems (Boverhof et al., 2004, Suh et al.,
2002, Fernando et al., 2012, Rasmussen and Pfau, 2012). For instance, a recent study
demonstrated activation of CH12.LX cells after asbestos exposure which correlated to the
ex vivo response of peritoneal B lymphocytes in terms of increased expression of IgA
(Rasmussen and Pfau, 2012). These studies suggest that the CH12.LX cell line will be a
good model system to elucidate the impact of Au-NPs as proposed in this study.
We also utilized a γ2b mini-locus model, the CH12.γ2b-3′Igh cell line, which is a sub
clone isolated from CH12.LX cells shown to endogenously express IgA antibodies and
stably transfected with one copy of the γ2b transgene regulated by the 3′IghRR (Henseler
et al., 2009). This cell line will be used for proof of concept studies to evaluate the
regulation of functional response (Ig) of CH12.LX cells by 3′IghRR.
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MATERIALS AND METHODS
Synthesis and characterization of gold nanoparticles (Au-NPs)
10 nm Au-NPs were synthesized by the Turkevich method (Polavarapu and Xu, 2009)
modified to obtain the 10 nm size. Briefly, an aqueous solution of 1 mM Tetrachloroauric
(III) acid monohydrate (~ 52% Au) (HAuCl4, MP Biomedicals) was brought to boil with
vigorous stirring. The concentration of sodium citrate solution (58.2 mM, Fischer
Scientific) was adjusted to obtain the desired 10 nm size of Au-NPs, and then 10 mL of
sodium citrate solution was added to the boiling HAuCl4 solution with stirring and boiled
for 10 min. The solution was stirred rapidly for an additional 15 min without heating. The
solution was then brought to boil again and 5 mL of additional sodium citrate solution
was added, after which the solution was stirred vigorously for an additional 10 min
without heating.
Cell culture conditions
All cells were grown in RPMI 1640 media (MediaTech, Herndon, VA) supplemented
with 10% bovine calf serum (Hyclone, Logan, UT), 13.5mM HEPES, 100 units/mL
penicillin, 100 µg/mL streptomycin, 2 mM L-glutamine, 0.1 mM nonessential amino
acids, 1.0 mM sodium pyruvate, and 50 µM β-mercaptoethanol. Cells were maintained at
37˚C in an atmosphere of 5% CO2. Cell viability was determined by assaying 1.0 mL of
cell suspension for Trypan Blue exclusion staining with a Beckman Coulter ViCell
instrument (Beckman Coulter, Brea, CA).
Cellular uptake of Au-NPs
Uptake of Au-NPs by the CH12.LX cells was determined as previously described
(Schrand et al., 2010). Briefly, CH12.LX cells were treated with 50 µg/mL of 10 nm Au-
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NPs for different intervals of time (0, 1, 3, 4 and 24 hr). Cells were then centrifuged at
3000 rpm and washed with 1x PBS. The cell pellet was then fixed using a 2% solution of
1:1 paraformaldehyde: gluteraldehyde. After washing with 1x PBS, the pellet was stained
with osmium tetroxide for visualization of the NPs. The pellet was then washed 5 times
with 1x PBS. After a series of dehydration steps with ethanol (50%, 70%, 90% and
100%), the pellet was cured in LR white resin (Electron Microscopy Sciences, Hatfield,
PA) overnight at 70˚C. The resin embedded pellet was then sectioned using a microtome
and imaged by TEM.
Transient transfection and luciferase assay
Cells (1.0x107) were resuspended in 200 µL of culture media with 10 µg of 3x-NF-B
plasmid and transferred to a 2-mm gap electroporation cuvette (Molecular BioProducts,
San Diego, CA). Cells were electroporated using an electro cell manipulator (ECM 630;
BTX, San Diego, CA) with the following voltage, capacitance, and resistance: 250 V,
150 µF, and 75 Ω (Romer and Sulentic, 2011). For each experiment, multiple
transfections with the 3x-NF-B plasmid were pooled in fresh media at 2.0x105cells/mL.
Immediately after transfection, the CH12.LX cells were treated with 0.05, 0.5 and 5
µg/mL of Au-NPs for 24 or 48 hr. For the CH12.IBAA cell line, the transfected cells
were immediately divided in half and half was treated with 100 μM IPTG for 2 hr to
activate the IPTG-inducible IBAA transgene while the other half was cultured in the
absence of IPTG to provide a control that lacked IBAA transgene expression. After
the 2 hr IPTG pre-treatment, the CH12.IBAA cells were incubated for 24 hr in the
absence (negative control) or presence of 5 μg/mL Au-NPs. Following the appropriate
incubation period, the transfected CH12.LX and CH12.IBAA cells were lysed with 1x
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reporter lysis buffer (Promega, Madison WI) and stored at -80C. To measure luciferase
activity, the whole cell lysate was thawed and cleared of cellular debris by centrifugation
at 14,000 rpm then 20 µL of whole cell lysate was mixed with 100 µL of luciferase assay
reagent (Promega) and luciferase activity was measured as relative light units (RLU) with
a luminometer (Berthold detection systems). Results are represented relative to the naive
control, which was set to 100 percent.
ELISA for γ2b and IgA expression
CH12.γ2b-3′Igh cells were treated with varying concentrations of 10 nm Au-NPs then
seeded (2 mL/well) into 48-well plates. To evaluate γ2b protein expression, cells were
seeded at a concentration of 3.0x104cells/mL and incubated for 48 hrs. For IgA protein
detection, cells were seeded at a concentration of 2.0x105cells/mL and incubated for 24
hr. Following the incubation period, cells were centrifuged at 3000 rpm then lysed with
mild lysis buffer (MLB, 1% NP-40, 150 mM NaCl, 10 mM NaPO4, 2 mM EDTA)
containing freshly added Complete Mini Protease Inhibitor Cocktail in a 1:3 ratio of
pellet to MLB. Lysed cells were cleared via centrifugation at 14,000 rpm for 5 min.
Supernatants were collected and stored at −80°C until analysis. To measure γ2b or IgA,
cell lysates were thawed on ice and protein concentrations were determined by the BioRad Protein Assay (Bio Rad, Hercules, CA). Samples were diluted to 2 or 3μg of total
protein/100 μL and analyzed for IgA or γ2b, respectively, by ELISA as previously
described (Henseler et al., 2009) (all antibodies were purchased from Bethyl Industries,
Inc.).
Protein corona analysis from Au-NP surface
Fresh whole cell lysate was isolated from 1.5 x 107 CH12.LX cells using MLB as
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described above. 10 nm Au-NPs (100 µg/mL) were added to 1 mL of the cleared lysate
and incubated at room temperature with rotation for one hour. Samples were then
centrifuged at 14,000 rpm for 10 min. The Au-NP pellet was washed with 1x PBS four
times and centrifuged for 7 min at 14,000 rpm between washes. For the final wash, the
Au-NP pellet was then transferred to a new 1.5 mL eppendorf and centrifuged a final
time. The supernatant was discarded and 50 µL of 2x loading dye (50 mM Tris-HCl, 10%
Glycerol, 4% SDS, and 0.4% of 14.2 M stock β-mercaptoethanol) was added to the AuNP pellet and boiled at 95°C for 7 min then vortexed for 30 seconds and centrifuged at
14,000 rpm for 10 min. Both the supernatant and Au-NP pellet was collected for further
analysis (i.e. UV-Vis, TEM, and Western blot).
Protein isolation
CH12.LX cells (1.0x107 cells/treatment) were treated with 5 µg/mL of 10 nm Au-NPs
over an 8 hr time course. Every 15 min, cells were pelleted via centrifugation at 3000 rpm
at 4°C and the supernatant was discarded. Whole cell lysate was isolated using MLB as
described above but with the addition of PhosStop Phosphatase Inhibitor Cocktail tablets
(Roche Diagonostics, Indianapolis, IN). Nuclear and cytoplasmic fractions were isolated
as previously described (Merluzzi et al., 2004) but with the following modifications. The
cell pellet was washed twice with 1x PBS and then resuspended in 50 µl ice cold buffer A
(10 mM Hepes pH 7.9, 10 mM KCl, 1.5 mM MgCl2, 0.1 mM EDTA, 0.5 mM PMSF, 0.5
mM DTT) and centrifuged at 800 x g for 10 min at 4°C. The supernatants were collected
as cytoplasmic extracts and the pellets were resuspended in 50 µL buffer B (20 mM
Hepes pH 7.9, 400 mM NaCl, 1.5 mM MgCl2, 0.1 mM EDTA, 5% glycerol, 0.5 mM
PMSF, 0.5 mM DTT) and incubated for 20 min on ice then centrifuged at 10,000 x g for
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30 min at 4°C. The supernatants were collected as nuclear extracts. Protein
concentrations were determined using the Bio-Rad Protein Assay. Loading dye was
added to 50 µg of protein to a final concentration of 1X and Western blot analysis was
performed.
SDS-PAGE and Western blot analysis
Whole cell lysates, cell fractions and the supernatant from the boiled Au-NP pellet were
thawed on ice and 50 µg of protein from both the whole cell lysates and cell fractions and
40 µL of eluent from the Au-NPs were electrophoresed through a Mini-PROTEAN TGX
4-20% gradient polyacrylamide gel (Bio-Rad) at 130 volts for 90 min. The proteins were
then transferred to a polyvinylidene fluoride (PVDF) membrane (Millipore, Bedford,
MA) using an electric current of 100 volts for 75 min. For the evaluation of the Au-NP
protein corona, the membrane was immediately washed two times with double distilled
water and stained with Sigma Aldrich’s Reversible Protein Detection Kit for Membranes
and Polyacrylamide Gels per manufacturer’s directions and imaged using a Fotodyne
Foto/Eclipse imager with incandescent background lighting. The membrane was destained and immersed in 3% BSA (bovine serum albumin)/TTBS (tris-buffered saline
with 0.05% Tween-20) blocking solution and rocked overnight at 4°C. The membrane
was then incubated at room temperature for 1 hr with rabbit anti-IKKα (ab47453, Abcam
Cambridge, MA) at a 1:1000 dilution in 3% BSA/TTBS. The membranes with whole cell
lysate and cell fractions, were blocked and then incubated at room temperature for 1 hr
with either anti-IBα (sc-371, Santa Cruz Laboratories, Santa Cruz, CA); anti-IBα
phosphorylated S32/36 (ab12135, Abcam); anti-RelA (A301-824A, Bethyl Laboratories,
Montgomery, TX); anti-p84 (5E10, Genetex, Simpson, PA); or anti β-actin (A5316,
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Sigma-Aldrich) at a 1:1000 (1:500 for anti-IBα phosphorylated S32/36) dilution in 3%
BSA/TTBS. After the primary antibody incubation, the blots were washed four times in
TTBS at 10 min intervals then incubated with HRP-conjugated secondary antibody (goat
anti-rabbit at 1:2500 or goat anti-mouse at 1:1000) for 1 hr. The blots were washed four
times in TTBS, then subjected to ECL substrate (Thermoscientific, Waltham, MA) and
analyzed on a Fuji LAS-3000 Bioimager (Tokyo, Japan).
Statistical analysis
Luciferase and ELISA data (n=3 for each treatment group) was normalized to the naive
control (set to 100%) and the means generated from several experiments were then
averaged and represented as the mean ± SEM. As indicated in the figure legends,
significant differences at p<0.05 or p<0.01 compared to the naive control were
determined by a 1-way ANOVA with a Dunnett’s post-hoc test.
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RESULTS AND DISCUSSION

Characterization and biocompatibility of Au-NPs
The Au-NPs showed a size distribution of 9 ± 1.5 nm (designated as 10 nm) as
determined by TEM (Fig. 5A). UV-Vis showed the absorbance spectra of ~525 nm,
distinctive to Au-NPs (Fig. 5B). The hydrodynamic diameter of Au-NPs was 9.7 + 0.047
nm in water, and 32.37 + 0.46 nm in media, as determined by DLS. This increase in NP
size in media can be attributed to the agglomeration of NPs owing to NP-protein
interactions in physiological fluids (Arvizo, 2012, Lundqvist et al., 2008). The
polydispersity index (pdI), which is a value between 0 (mono-disperse) and 1 (highly
polydisperse) (Murphy et al., 2010), was 0.352 in water, confirming the uniform size
distribution and increased to 0.568 in media suggesting increased polydispersity which is
indicative of agglomeration in media. After thorough characterization, Au-NPs were
utilized to study their impact on B-lymphocyte cell line.
Citrate-stabilized Au-NPs have been demonstrated to be toxic to a variety of cell
types in both in vivo and in vitro studies (Yu et al., 2007, Marquis et al., 2009, Gao et al.,
2011, Abdelhalim and Jarrar, 2011a, Ng et al., 2011, Vecchio et al., 2012). However, we
did not observe any change in cell morphology or viability after treatment with Au-NPs
(Fig. 6 and Fig. 7). TEM imaging suggests cytoplasmic localization of Au-NP by 4 hr,
which appeared to increase by 24 hr (Fig. 8). Aggregates of Au-NPs were observed in
membrane-bound cellular organelles, presumably suggesting endoplasmic localization
(Fig. 8B and C). Monodispersed Au-NPs were also seen in the cellular cytoplasm (Fig.
8D).
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Fig 5: Characterization of gold nanoparticles.
Au-NPs were synthesized by the Turkevich method but modified to obtain the desired
size of 10 nm. A) Nanoparticle suspensions were dried on formvar/carbon film-coated Cu
grids and Transmission electron microscopic analysis of the particle morphology and size
was performed. B) UV-Vis absorption spectra of Au-NPs showing absorption peak at
~525 nm

Table 2: Size assessment of citrate- stabilized (as synthesized) ~10 nm Gold
Nanoparticles.
The primary size (Dp) was obtained by TEM. Hydrodynamic diameter (DH) of citratestabilized Au-NPs (as synthesized) obtained using Dynamic Light Scattering confirmed
the. Poly dispersity Index (PdI) was determined to assess uniformity in size distribution
of Au-NPs.
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Fig. 5

Table 2
Dp (nm) $

DH*
(nm, water)

PdI
(water)

DH*
(nm, media)

PdI
(media)

9.0 ± 0.05

9.7 ± 0.047

0.352

32.37 ± 0.46

0.568
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Fig 6: Au-NP treatment does not impact CH12.LX cell morphology.
CH12.LX cells at 2.5x105 cells/ml were incubated with (B) or without (A) 5μg/ml of
10nm Au-NPs. After 24 hr, cells were fixed and stained for actin (Red) and DNA (Blue)
for fluorescence imaging. Images are representative of two separate experiments (n=3 for
each treatment).
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Fig. 6
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Fig 7: Au-NP treatment does not impact CH12.LX cell viability.
CH12.LX cells at 2.5x105 cells/ml were incubated with and/or without different
concentrations (0.0, 0.05, 0.5 and 5μg/ml) of 10nm Au-NPs. After 24 hr, cell viability
was assessed using trypan blue exclusion staining and represented relative to the naïve
control (0.0µg/mL Au-NPs). The results are representative of at least three separate
experiments (n=3 for each treatment group).
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Fig. 7
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Fig 8: Uptake of gold nanoparticles by CH12.LX cells.
CH12.LX cells (5x105 cells per mL) were treated with 50 µg/mL of 10 nm Au-NPs for
varying time intervals (0, 1, 4 or 24 h) then characterized by TEM. Depicted are the
images of control cell in the absence of Au-NPs (A) and cells incubated with Au-NPs for
4 h (B) or 24 h (C). TEM images are representative of two separate experiments (n = 3
for each treatment and time point).
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Fig. 8
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Au-NPs activate the NF-κB pathway in B-lymphocyte cell line
A few mechanistic studies have demonstrated that Au-NPs are capable of
inhibiting the NF-B pathway in macrophage cell lines suggesting their capability to
modulate cellular signaling pathways and cellular function (Chiau-Yuang et al., 2012, Ma
et al., 2010, Sul et al., 2010). Using a 3x-NF-B luciferase reporter plasmid, we
evaluated the effect of Au-NPs on NF-κB activity in the CH12.LX B-lymphocyte cell
line, which was treated with varying concentrations of 10 nm Au-NPs for 24 or 48 h. We
observed a significant induction of NF-B activity at both 24 and 48 hr but this effect
was limited to the highest Au-NP concentration (5μg/ml) with no effect at lower
concentrations (Fig. 9A and B). Our results contrast those reported in the aforementioned
studies where an inhibitory effect of Au-NPs on NF-B pathway was reported. This
difference could be attributed to the cellular models, or the size and functionalization of
Au-NPs, and/or the treatment conditions. Additionally, the Au-NPs utilized in these
studies were either larger (~150nm) and synthesized using a different method (Sul et al.,
2010) than the citrate-stabilized NPs used in our study (~10nm), or were the same size
but coated with Polyethylene glycol (Chiau-Yuang et al., 2012). Furthermore, the
treatment concentrations used for the ~10 nm Au-NPs were considerably higher ranging
from 10-40μg/mL in one study (Chiau-Yuang et al., 2012) and10-80 μg/mL in another
study (Ma et al., 2010).
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Fig 9: Au-NPs activate the NF-κB signaling pathway.
CH12.LX cells were transiently transfected with the 3x-NF-κB luciferase reporter
plasmid then cultured at 2.0x105 cells/mL with varying concentrations (0.0, 0.05, 0.5 and
5 µg/mL) of 10 nm Au-NPs. After a 24 h (A) or 48 h (B) incubation, cells were lysed and
cellular extracts evaluated for luciferase enzyme activity as measured in relative light
units (RLU) and represented on the y-axis as NF-κB activity (mean ±SEM) relative to the
naive control (0.0 µg/mL Au-NP, set to 100%). Mean ± SEM was generated from three
separate experiments. ** Statistical significance at p < 0.01 compared to 0.0 µg/mL AuNP control via 1-way ANOVA and a Dunnett's posthoc test.
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Fig. 9
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Au-NPs increase IgA production and 3ʹIghRR activity in a B-lymphocyte cell line
Biodistribution studies indicate bulk localization of Au-NPs in liver and spleen
post- intravenous administration. Spleen is one of the major lymphoid organs in the body
and contains a variety of immune cell types such as the B cells, T cells and macrophages.
The main function of B-cells is to produce antibodies (Ig) with specificity for antigens or
non-self molecules. Antibodies are composed of two different polypeptides, the Ig heavy
and light chains. Each antibody has two identical heavy and light chains which are
encoded by heavy- and light-chain Ig genes respectively. Antibody production is
controlled by a functional interaction of several regulatory elements such as promoters
and enhancers within the Ig heavy chain (Igh) and light (Igl) chain loci (Vincent-Fabert,
2010, Chauveau et al., 1998, Sen and Baltimore, 2006). Two transcriptional enhancer
regions in the Igh locus, namely, the intronic enhancer (Eμ) and the 3ʹ regulatory region
(3ʹIghRR) have been well studied in their role in B-cell maturation and function (Perlot
and Alt, 2008, Giannini et al., 1993, Ong et al., 1998, Chauveau et al., 1998). The
3ʹIghRR has multiple NF-κB binding sites that have been shown to play a role in
3ʹIghRR activity (Michaelson et al., 1996, Pinaud et al., 2011, Vincent-Fabert, 2010). To
determine if treatment with Au-NP leads to a functional effect on an Ig transcriptional
regulatory element (i.e. 3ʹIghRR) and on endogenous antibody production, we utilized a
variant of the CH12.LX B-lymphocyte cell line (CH12.γ2b-3ʹIghRR) that stably
expresses an Ig heavy chain (2b) under the transcriptional regulation of the 3ʹIghRR.
The CH12.γ2b-3ʹIghRR cells have been previously characterized and shown to
endogenously express IgA antibodies as well as one copy of the γ2b transgene (Henseler
et al., 2009). The CH12.γ2b-3ʹIghRR cells were treated with varying concentrations of
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10 nm Au-NPs (0.0, 0.05, 0.5 and 5μg/mL) and evaluated by ELISA for γ2b and IgA
protein levels. Similar to the effect on NF-κB, 5 μg/mL Au-NP significantly increased
3ʹIghRR-regulated γ2b transgene expression (Fig. 10A). IgA levels were also
significantly increased but at a lower concentration (0.5 μg /mL) of Au-NP (Fig. 10B)
suggesting an enhanced sensitivity of IgA to Au-NPs perhaps through an effect on both
heavy and light chain expression or a post-transcriptional modification.
IKK signal transduction proteins adsorb to Au-NPs
NPs have been shown to adsorb proteins (and other biological molecules) on their
surface, often referred to as ‘protein corona’, when dispersed in biological solutions such
as culture media or blood (Arvizo, 2012, Lundqvist et al., 2008). The composition of the
protein corona depends on the surface functionalization of NPs (Mortensen, 2013) and
duration of NP exposure to the proteins (Casals et al., 2010, Barrán-Berdón and Laganà,
2013). Since the 10 nm Au-NPs are taken up by the CH12.LX B cells (Fig. 8), Au-NPs
could interact with membrane-bound and/or intracellular proteins potentially altering
signal transduction pathways and normal cellular function. To determine if Au-NPs and
cellular proteins physically interact, the dispersion and aggregation pattern of Au-NPs
before and after incubation with whole cell protein lysate was assessed using UV-Vis
spectroscopy and TEM. Cell lysate from CH12.LX cells, was incubated with Au-NPs for
1 h then either analyzed immediately by UV-Vis (Fig. 11A, curve a) or after proteins that
specifically bound the Au- NPs were extracted (Fig. 11A, curve b).
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Fig 10: Au-NPs increase 3´IghRR-regulated γ2b transgene expression and IgA
secretion.
CH12.γ2b-3´IghRR cells at 3.0x104 cells per mL were cultured with varying
concentrations (0.0, 0.05, 0.5 and 5 µg/mL) of 10 nm Au-NPs. After a 48 h (γ2b) or 24 h
(IgA) incubation, cells were lysed and diluted to 3 or 2 μg whole cell protein per 100 mL
and evaluated by ELISA to determine ng of γ2b per 3 mg protein (A) or ng of IgA per 2
μg protein (B). Expression of γ2b or IgA (mean ± SEM) relative to the naive control (0.0
µg/mL Au-NP set to 100%) is represented on the y-axis. Mean ± SEM was generated
from three separate experiments. * and **, statistical significance at p < 0.05 or p < 0.01,
respectively, compared to 0.0 µg/mL Au-NP control via 1-way ANOVA and a Dunnett's
post-hoc test.
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The UV-Vis absorption spectra demonstrated a characteristic peak for 10 nm AuNPs at 525 nm for the samples containing Au-NPs (compare Fig. 11A, curves a and c to
Fig. 5B). Peaks at lower wavelengths likely represent proteins (Fig. 11A, curves a and b)
since these peaks are not present when the Au-NPs are analyzed in the absence of cell
lysates (Fig. 11A, curve c). Interestingly, proteins extracted from the Au-NP induced
more distinct peaks as compared to the whole cell lysate (Fig. 11A, compare curves a and
b), which likely reflects selective binding of specific proteins to the Au-NPs.
Additionally, no absorption for Au could be seen in the protein sample extracted from the
Au-NP pellet after heating under reducing conditions (Fig. 11A, curve b), indicating little
or no contamination of the sample with Au-NPs. These results suggest that a protein
corona is formed on the surface of the Au-NP which is further supported by TEM
analysis of Au-NPs before and after incubation with whole cell protein lysate. After
incubation with cell lysate, the Au-NPs are less agglomerated perhaps due to a protein
corona which keeps them separated from each other (Fig. 11C). Once the proteins are
removed from the surface of the particles by heating under reducing conditions, the AuNPs agglomerate (Fig. 11D). This agglomeration of Au-NPs can be attributed to the
absence of the stabilizing agent (i.e. sodium citrate or protein corona).
To further investigate the association of Au-NPs with intracellular proteins,
CH12.LX proteins that specifically associated with Au-NPs were eluted by heating under
reducing conditions and resolved by SDS-PAGE and Western blot analysis. Reversible
membrane staining revealed several protein bands, suggesting a broad spectrum of
proteins binding to the Au-NPs (Fig. 12A, lane 3). However, there was less banding as
compared to the whole cell lysate control (Fig. 12A, compare lanes 2 and 3) supporting
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Fig 11: Protein corona characterization using UV-Vis spectroscopy and TEM
imaging.
(A) Whole cell lysate from CH12.LX cells was incubated with 10 nm Au-NPs for 1 h
then analyzed by UV-Vis either immediately (curve a) or following extraction of proteins
that specifically bound the Au-NPs (curve b). Curve c represents the Au-NPs alone
control (absence of cell lysate). (B–D) Corresponding TEM imaging for Au-NPs prior to
(B) and after (C) incubation with whole cell lysate from CH12.LX cells and following
removal of the protein corona (D). Results are representative of three separate
experiments.
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protein specificity for the Au-NPs. Additionally, the absence of detectable bands in the
Au-NP only (in lysis buffer) control (Fig. 12A, lane 4) demonstrated that the elucidated
bands are not merely an artifact from the Au-NPs or the protein extraction process. AuNPs have an inherent affinity for –thiol groups which might make the proteins with –
cysteine residues as intracellular binding targets for NPs. Thiol reactive compounds
(including gold compounds) have been shown to physically interact and inactivate the
IKK complex, by specifically inhibiting both IKKα and IKKβ. Therefore, using western
blotting, we evaluated the physical interaction of Au-NPs with IKK subunits. Strong
IKKα and IKKβ bands were detected in the protein sample eluted from the Au-NPs (Fig.
12).
Au-NPs activate the canonical NF-κB signaling pathway
Au-NPs induce NF-κB activation (Fig. 9) and demonstrate the potential to
physically interact with IKKα and IKKβ (Fig. 12) perhaps indicating a direct interaction
of Au-NPs with the canonical pathway of NF-κB activation. Canonical activation
involves IKK-dependent phosphorylation of IκBα at serines 32 and 36, which leads to
ubiquitination and degradation of IκBα. Degradation of IκBα releases NF-κB/Rel dimers
(i.e. p50/RelA or p50/c-Rel), which translocate to the nucleus, bind DNA, and modulate
gene transcription (Fig. 3). To determine if Au-NPs activate the canonical pathway,
CH12.LX cells were treated with 5 μg/mL of 10 nm Au-NPs for up to 8 h. Whole cell
lysates were isolated every 15 min then analyzed by Western blot analysis for IκBα and
its serine 32 and 36 phosphorylated form (P-IκBα). We observed elevated P-IκBα from
approximately 4.75 to 6h after treatment with Au-NPs (Fig. 13). Correspondingly, IκBα
degradation occurred around 6.25 to 7.5 h following Au-NP treatment and rebounded
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around 6.5 to 7.5 h (Fig. 13). The window of phosphorylation, degradation and rebound
varied slightly between experiments. The consistent degradation pattern of IκBα in
response to Au-NP exposure supports NF-κB activation through the canonical signaling
pathway. Since IκBα degradation should lead to a rapid increase in nuclear localization of
NF-κB, the cytoplasmic and nuclear fractions were isolated from CH12.LX cells treated
with 5 μg/mL of 10 nm Au-NPs and then probed for RelA (p65). The cell fractions were
also probed with β-actin and p84 (a nuclear matrix protein), which served as loading
controls for the cytoplasmic and nuclear fractions, respectively. β-Actin has also been
shown to be nucleoplasmic (McDonald et al., 2006, Blessing et al., 2004, Olave et al.,
2002) and was detected in the nuclear fraction (Fig. 13); p84 was only detected in the
nuclear fraction. Overall, there was a general trend for increased nuclear RelA and
decreased cytoplasmic RelA around 6.25 h (Fig. 13) that corresponded to the kinetics of
IκBα degradation (Fig. 12).
Taken together, our results support modulation of canonical NF-κB signaling
pathway by citrate-stabilized 10 nm Au-NPs, leading to induction of NF-κB activity
which correlated with the increased activation of 3ʹIghRR and Ig expression (Fig. 15).
However, it is unclear whether the observed effects are due to direct interaction of AuNPs with IKKs. Gold (compounds and NPs) have inherent affinity for sulfhydryl group
which makes the thiolated biomolecules their probable biological targets (Wang and
Yang, 2010, Mizukoshi, 2006). For instance, gold compounds have been previously
shown to inhibit both IKK and IKKsubunits of IKK (Jeon et al., 2000).
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Fig 12: The Au-NP protein corona contains both IKKα and IKKβ.
Whole cell lysate from CH12.LX cells was incubated with 10 nm Au-NPs for 1 h. The
protein corona was extracted from the Au-NP surface and subjected to Western blot
analysis. The membrane was stained with reversible protein staining (A) or probed with
antibodies against IKKα (B) or IKKβ (C). The Au-NP control represents AuNP in the
absence of protein lysate. Results are representative of three separate experiments.
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Additionally, we saw uptake and cytoplasmic localization of Au-NPs in B-cells which
supports the possibility of molecular interactions between Au-NPs and important
signaling pathways. Alternatively, induction of reactive oxygen species (ROS) have been
reported previously post-Au-NP treatment (Jia et al., 2009) and ROS is a well-known
modulator of NF-κB transcriptional activity (Morgan and Liu, 2011). Indeed, previous
results have demonstrated a biphasic effect of H2O2 on 3ʹIghRR activity and endogenous
Ig heavy chain expression (i.e. induction at 30–40 μM concentrations and inhibition at
100–200 μM concentrations) (Romer and Sulentic, 2011). Therefore, ROS may play an
additional role in the effects of Au-NP on NF-B activation and Ig expression.
Alternatively, thioredoxin system might also play a role in the Au-NP induced NF-B
activation. Trx has been shown to have a C-terminal Cys-selenocysteine sequence that
interacts with the enzyme’s catalytic site and also participates in the thiol-disulphide
exchange reactions which help in keeping the redox balance of proteins inside the cell.
Thioredoxin has been shown to play a dual role in keeping the transcriptional activity of
NF-B in check both in the cytoplasm and in the nucleus. In the cytoplasm, TRX
interferes with degradation of IK- thereby inhibiting the nuclear translocation of NFB complex. On the contrary, TRX has been shown to translocate to the nucleus in
response to NF-B activation where it reduces the p50 subunit of NF-B for efficient
binding to target genes (Maulik and Das, 2008). Therefore, Au-NPs might be able to
physically interact with TRX owing to their inherent affinity for –thiols which might
modulate the downstream NF-B activity. But this is an area which needs indepth
experimental analysis.
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Fig 13: Au-NPs cause phosphorylation and subsequent degradation of IκBα.
CH12.LX cells (5.0x105 cells/mL) were treated with 5 μg/mL of 10nm Au-NPs for the
indicated time points (C). Cell lysates were prepared and Western blot analysis was
performed with antibodies against IκBα, the serine 32 and 36 phosphorylated form of
IκBα [P-IκBα (S32/36)], and β-Actin. Results are representative of three separate
experiments.
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Fig 14: Au-NPs increases nuclear RelA.
CH12.LX cells (1x107 cells per treatment) were treated with 5 µg/mL of 10 nm Au-NPs
for the indicated time. Cytoplasmic and nuclear fractions were prepared and Western blot
analysis was performed with antibodies against RelA, IBα, p84 and β-actin. NA denotes
the naïve untreated control. Results are representative of three separate experiments.
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Although the mechanism is not completely understood, the implications of NF-B
activation by Au-NPs point towards functional dysregulation of B-cells. The modulation
of B-cell function by citrate-stabilized Au-NPs, with no immediate toxicity, can have
detrimental effects in terms of development of autoimmune diseases and cancer.
Therefore, toxicological analysis of Au-NPs (and other NPs) should include assays that
encompass parameters to assess overt toxicity as well as functional endpoints.
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Fig 15: Proposed mechanism of NF-κB activation after treatment with 10 nm AuNPs.
NF-κB activation through ‘canonical’ pathway is depicted. The present study supports
3ʹIghRR activation and increased Ig expression by 10 nm Au-NPs that is mediated
through activation of the ‘canonical’ NF-κB signaling pathway. Investigation of the
underlying mechanism of NF-κB activation revealed a physical interaction between 10
nm Au-NPs and IKKα and IKKβ, which may play a role in Au-NP-induced NF-κB
activation.
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IV CHAPTER II: SHEAR FLOW INFLUENCES NP AGGLOMERATION AND
BIONANOINTERACTION.
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SUMMARY
The in vivo studies are ideal to evaluate nano-biointeraction, however, the cost for
animal studies, pose great limitations. Therefore, in vitro models are pursued to study
toxico-physiological aspects of the ‘BBB’ (Grant et al., 1998, Toth et al., 2011, Garberg,
2005, Naik and Cucullo, 2012). Whereas, the issue of NP aggregation and sedimentation
make the existing static in-vitro ‘BBB’ models incapable of accurately predicting NP
toxicity, the high cost and inability to analyze multiple endpoints, associated with the
existing dynamic ‘BBB’ models make them infeasible. Therefore, the goal of SA2 was to
modify a previously described static in vitro ‘BBB’ model by adding a constant flow of
media containing NPs and then studying the NP trafficking across the endothelial cell
barrier to determine impact on astrocytic function. The concentration of Au-NPs was
5μg/mL for all conditions because; 1) we observed the greatest induction of NF-κB
activity in CH12.LX cell line in SA1 at 5 μg/mL, and 2) this concentration of Au-NPs is
similar to that observed in blood post-Au-NP treatment in vivo after bulk localization in
liver and spleen. For instance, the range of citrate-Au-NP (~18 nm) concentration in
blood after treatment of rat model with 0.6-1 mg/kg of NPs was found to be between ~712 μg/mL (Morais, 2012). Another study with initial IV dose of 10 nm Au-NPs at 80
μg/mL demonstrated the blood concentration range of 0.5-2.6 μg/mL (De Jong et al.,
2008). Since in both of these studies 70-80% of the initial dose of NPs was found in the
liver, spleen and blood, we assumed that the concentration still found in the blood can
potentially cross the ‘BBB’. Additionally, the effect of shear flow on NP aggregation and
deposition was studied in the modified model.
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CELL MODELS
We utilized a murine brain endothelial cell line, bEnd.3 cells to represent the
brain vasculature in the model-set-up. This cell line has been extensively used to study
physiological aspects of ‘BBB’ such as response to endotoxins (Bannerman and
Goldblum, 1999, He et al., 2011, He et al., 2012, Seok, 2013, Yen et al., 1997). bEnd.3
cells have also been used as model cell type to study drug transport and to test drugcarrier systems across the ‘BBB’(Xie et al., 2012, Pang, 2012).
We also utilized mouse type-III astrocytic cell line, C8-D30, originally derived from
cerebellum of eight-day-old C57B1/6 mice (Alliot and Pessac, 1984). This cell line has
been used to study cytokine mediated astrocytic responses (An et al., 2011). This cell line
has also been used in studies to identify cell specific therapeutic targets in CNS such as
receptor expression (IL-1) and signaling response (JAK/STAT) (Tsai et al., 2012, Wang,
2012).
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MATERIALS AND METHODS
Model set-up
24 well plates (Corning Inc., Corning, NY) were used to develop the model (Fig. 17).
Two holes were drilled in the lid (0.2 cm apart) of the plate over each well and
connectors were inserted in the holes. Two tubes (Internal Diameter 1/16 in, Outer
Diameter 1/8 in, Width 1/32 in, Length 1 cm) were inserted on the bottom part of the
connector (which goes in the luminal side of the transwell). Tubes were inserted on the
top part of the connector. The top tubing was connected to the peristaltic pump (Idex Inc.,
Lake Forest, IL). Each well had an inlet and outlet tubing coming from the peristaltic
pump. The bottom tubing was inserted in the transwell. The geometry was set-up in the
multi-physics software program Comsol (version 4.2a) based on the model set-up
described above.
Matrigel coating of the Transwell™ membrane
The abluminal side of the Transwell™ membrane was coated with matrigel (BD San
Jose, CA) using a method described previously with modifications to obtain a thin
coating on the membrane (Li et al., 2010). Briefly, matrigel was diluted in serum free
media to the concentration of 465 g/mL. The abluminal side of the Transwell membrane
was coated with 50 L of the diluted matrix. The transwells were incubated for 4 hours at
37°C.
Cell lines and culture conditions
Brain endothelial cells (bEnd.3 cells, CRL-2299, American Type Culture Collection
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(ATCC), Manassas, VA) and Astrocytes (CRL-2534, (ATCC) were grown according to
the supplier’s instructions in dulbecco’s modified eagle medium (DMEM, ATCC #302002) supplemented with 10% Fetal Bovine Serum (ATCC # 3020). Cells were
maintained in a humidified cell culture incubator at 37°C and 5% CO2. For all
experiments, bEnd.3 cells were seeded at a density of 1.0 x 105 cells/ membrane (0.4 m
pore size, 24 well; Corning Inc, Lowell, MA) and were allowed to reach confluence (8
days). The media was changed every other day during the course of 8 days. After 8 days
in culture, permeability assays and Transendothelial electrical resistance (TEER)
measurement was performed on the cells.
Co culture set-up
To co-culture bEnd.3 cells and C8-D30 cells, matrigel coated transwells were utilized.
C8-D30 cells at 2.8X104 cells/ membrane were seeded on the matrigel-coated abluminal
side of the transwell membrane (Fig. 17). The inverted transwells were incubated for 3
hours in a humidified cell culture incubator at 37°C and 5% CO2. The transwells with
astrocytes were then put in a 24 well plate and incubated. After 24 hours, bEnd.3 cells at
1x105 cells/membrane were seeded on the luminal side of the transwells. The transwells
were then maintained at 37°C and 5% CO2 in the incubator for 8 days.
Characterization of mono- and co-culture on transwell membrane
TEM imaging of cells on membrane
bEnd.3 cells at 1.0 x 105 cells/ Transwell membrane were allowed to reach confluence (8
days). The media was changed every other day during the course of 7 days. After 8 days
the cells were fixed on the membrane using a 2% solution of 1:1 paraformaldehyde:
gluteraldehyde. After washing with 1x PBS, the membrane with cells was stained with
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osmium tetroxide. The membrane was then washed 5 times with 1x PBS. After a series of
dehydration steps with ethanol (50%, 70%, 90% and 100%), the membrane was
transferred to a beam capsule. The membrane was then cured in LR white resin (Electron
Microscopy Sciences, Hatfield, PA) overnight at 70˚C. The resin embedded membrane
was then sectioned using a microtome and imaged by TEM.
Transendothelial electrical resistance (TEER)
TEER readings were measured using an EVOM volt ohmmeter (World Precision
Instruments, Sarasota, FL) as previously described (Mark and Davis, 2002). Electrical
resistance was measured using chop-stick electrodes and TEER values (Ω cm2) were
determined by subtracting the resistance of blank filters (no cells) from sample
resistances.
Paracellular Permeability
Paracellular solute permeability of the barrier cells was assessed for FITC-Dextran (In
Vitro Vascular Permeability Assay, EMD Millipore, Billerica, MA). Manufacturer’s
instructions were followed with modifications. Briefly, bEnd.3 cells at 1X105 cells/
transwell membrane, were cultured on the transwell membranes. After reaching
confluence (after 8 days), 100 µl of FITC-Dextran diluted in complete media (1:40
dilution) was added to the luminal side. 250 µl of complete media was added in the
receiver tray. After incubating at room temperature for 20 min, 100 µl was collected from
the receiver tray and fluorescence was recorded using the plate reader.
Functionalization of glass coverslips with aminosilane:
Glass coverslips were functionalized with aminosilane as described previously
(Ungureanu et al., 2010). Briefly, German borosilicate glass coverslips (5 mm diameter,
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#1 thickness, #64-0700 [CS-5R], Warner Instruments, Hamden, CT) were rinsed with
100% ethanol 3 times, then submerged in 5% solution of (3-Aminopropyl) triethyl silane
(APTES, Sigma-Aldrich, St. Louis, MO) and ethanol for 15 min. After functionalization,
the coverslips were rinsed 5 times with 100% ethanol. The coverslips were allowed to air
dry completely under sterile conditions (in biohood) before being used for deposition
experiments.
Quantification of Au-NPs
Mono- and/or co-culture set-up was treated with different sizes of Au-NPs in static or
dynamic conditions. After 24 hours, 100 μL of media was collected from top and bottom
wells of the transwell and the receiver tray respectively and transferred to 15 mL conical
tube and frozen at -80°. The membrane with the cells was washed 3 times with warm 1X
PBS. The membrane was then cut out of the transwell and transferred to a 15 mL conical
tube containing 500 μL of deionized water and frozen at -80° C. After thawing, 75 μL of
1% Triton-X 100 (Fisher Scientific, Pittsburg, PA) was added to the media and
membrane samples. 146 μL of aqua regia (1:5.5 v/v ratio of 69% Nitric acid [HNO3,
Sigma-Aldrich, St. Louis, MO] to 37% Hydrochloric acid [HCl, Fisher Scientific,
Pittsburg, PA]) was added to the samples. After adding 3 μL of internal standard/sample
(Perkin Elmer, Waltham, MA), the volume was brought up to 1.5 mL using deionized
water. ICP-MS (Perkin Elmer Nexion 300D, Waltham, MA) was used to determine the
contents of Au in the samples prepared above. Calibration plots of standards of Au were
obtained by injecting a series of standard solutions (2, 50, 100, 300 ppb, in 1% HNO 3and
3% HCl), with flow rate of 1.0 mL/min.
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Cell imaging
bEnd.3 and C8-D30 cells were co-cultured on transwell membranes. The set-up was
treated with 5, 10 or 30 nm of Au-NPs for 24 hr with or without flow of media. The cells
were

then

fixed

on

the

membrane

using

a

2%

solution

of

1:1

paraformaldehyde:gluteraldehyde. After washing with 1x PBS the membrane was cut out
of the transwell and placed on a 4 chambered slide (BD San Jose, CA) and permeabilized
with 0.1% Triton–X-100 for 5 min. The membrane with cells was then washed 2 times
with 1X PBS and incubated in a 1% solution of Bovine Serum Albumin (BSA
Calbiochem, Billerica, MA) for 30 min. The BSA solution was removed and the
membrane with cells was then stained, at room temperature for 20 min, with 1 mL of
Alexa Fluor 555 Phalloidin (1:40 Solution of Alexa Fluor in 1% BSA, Life Technologies,
Grand Island, NY). The membrane was then washed twice with 1X PBS. The chambers
of the slides were then removed according to manufacturer’s instructions. After letting
the samples air-dry for 5 min, a few drops of Prolong Gold Antifade agent with DAPI
counterstain (Life Technologies, Grand Island, NY) were added on the top of the
membrane and covered with a coverslip and sealed in place by applying regular clear nail
polish to the edges. After overnight curing, fluorescent and dark field images of the
samples were obtained. The slides were inverted and a few drops of immersion oil were
applied to the back of the slides. The slides were then secured on the Olympus IX71
Microscope platform that was coupled with the URI System. QCapture Pro Imaging
Software was used to capture and store images.
ELISA
Multianalyte ELISA kit (#MEM-004A, SABiosciences, Valencia, CA) was used to
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measure protein levels of inflammatory cytokines (IL1α, IL1β, IL2, IL4, IL6, IL10, IL12,
IL17α, IFNγ, TNFα, G-CSF, GM-CSF). Manufacturer’s instructions were followed for
collecting and analyzing the protein levels. The co-culture set-up was treated with
different sizes of Au-NPs in static or dynamic conditions. After 24 hours, 250 μL of
media was collected from the bottom of the 24 well receiver tray. The collected media
was then centrifuged at 14,000 rpm for 10 min to remove nanoparticles that might have
reached the bottom media and also to remove any cell debris. The aliquots of the media
were then stored at -80°C before use.
Statistical analysis
For TEER and DLS measurements (n=3 for each treatment group), means generated from
several experiments were averaged and represented as the mean ± SEM.

For

permeability assay, data (n=3 for each treatment group) was normalized to the control
(membrane without cells) (set to 100%) and the means generated from several
experiments were then averaged and represented as the mean ± SEM. Significant
differences at p<0.05 or p<0.01 were determined by a 1-way ANOVA with a
Bonferroni's Multiple Comparison Test.

80

RESULTS AND DISCUSSION
NP characterization in dynamic versus static conditions
The NPs utilized in this study were characterized by TEM, DLS and UV-Vis in
water and culture medium (Fig. 16, Table 3). The primary particle size for 5, 10 and 30
nm Au-NPs, as determined by TEM, was 4.4 ± 0.70, 9.0 ± 0.05 and 27.6 ± 2.1 nm
respectively. The hydrodynamic diameter (DH) of NPs dispersed in water was 6.10 ±
0.12, 10.79 ± 0.57 and 28.30 ± 0.36 nm for 5, 10 and 30 nm NPs respectively, as
determined by DLS. The DH characterized using DLS is typically slightly larger than the
primary diameter determined via TEM due to the formation of a hydration layer upon
dispersion (Kittler et al., 2009, Murphy et al., 2010) (Table 3).
Previous studies have reported that NPs form agglomerates in cell culture media
due to decreased repulsion between particles in the presence of salts (Mahl et al., 2010)
and formation of ‘protein corona’ on their surface (Lundqvist et al., 2008, Arvizo et al.,
2012). We observed a significant increase in the size of 5 and 10 nm Au-NPs in media
(Table 3, compare DH in water to DH in media), while the 30 nm Au-NP hydrodynamic
diameter increased by only about 3 nm, indicating the formation of protein-NP
composites comprised of about 1 particle each. Reduction in primary NP size results in a
substantial increase in the specific surface area and surface Gibbs free energy (Wu et al.,
2011). In order to reduce the surface free energy, NPs tend to agglomerate leading to
reduction in surface area (Pereira-Almao, 2011). Not only did the NPs agglomerate in
media, the agglomerates varied in sizes, making the NP solution polydisperse as indicated
by the increase in PdI (Table 3, compare PdI values in water to PdI values in media).
Moreover, based on the results for PdI in media, the 5 nm solution of NPs was most
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polydisperse (0.636), followed by 10 nm (0.568) and then 30 nm (0.497). The increased
tendency to form polydisperse samples corresponding with a reduction in primary
diameter may also be related to the Gibbs free energy phenomenon described above.
In all three cases, the agglomerates were stabilized through the adsorption of
serum proteins (Lundqvist et al., 2008, Arvizo et al., 2012). The zeta potential (ζ) for 5,
10 and 30 nm Au NPs dispersed in water was -32.0 ± 1.6 mV, -32.9 ± 0.2 mV and -40.2
mV ± 1.8 mV, respectively. These values for ζ potential changed to -9.3 ± 1.1 mV, -8.3±
0.8 mV and -8.6 ± 0.8 mV when NPs were dispersed in complete cell culture media for 5,
10 and 30 nm Au NPs, respectively which might indicate adsorption of serum proteins,
such as Bovine serum albumin, on the NP surface (Alkilany and Murphy, 2010, Patil et
al., 2007). In a previous study, a shift in ζ to -11.1 mV was observed for 10 nm citratestabilized Au NPs dispersed in serum-supplemented media (Mukhopadhyay et al., 2012),
which is similar to the results presented here.
After characterization of NPs, we evaluated the agglomeration of three sizes of
Au-NPs (5, 10 and 30 nm) in complete media, under dynamic conditions using our
custom set-up (Fig. 17a and b), and compared it to that of static conditions. NP solutions
(5 μg/mL) were run for 24 h in continuous flow (1.5 mL/min) in addition to solutions
incubated under static conditions. Based on DLS results, the 5 and 10 nm NPs formed
agglomerates containing several particles, while the 30 nm NPs formed agglomerates
containing 1-2 particles (Table 4).
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Fig 16: Characterization of Au-NPs using UV-Vis spectroscopy and TEM imaging.
Depicted are the TEM images of 5nm (a), 10 nm (b) and 30 nm (c) Gold nanoparticles
with their respective UV-Vis absorption peaks (d-f), where x axis is the wavelength and y
axis is the absorbance. The 100 nm scale bar applies to all images
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Fig. 16
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Table 3: Characterization of Au-NPs using DLS
Dynamic Light Scattering (DLS) results for Au-NPs.
*Hydrodynamic diameter (DH) of citrate-stabilized Au-NPs (as synthesized) obtained
using DLS. Poly dispersity Index (PdI) was determined to assess uniformity in size
distribution of Au-NPs. $The primary size obtained by TEM. ɸSurface charge of particles
was measured in deionized water and in media and listed under Zeta (ζ) potential.
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Table 3

$

*

(nm, water)

PdI
(water)

ζ potential
(water)

4.4 ± 0.70

6.10 ± 0.12

0.299

9.0 ± 0.05

10.79 ± 0.57

27.6 ± 2.1

28.30 ± 0.36

D (nm)
p

D

H

ɸ

*

ɸ

(nm, media)

PdI
(media)

-32 ± 1.56

36.98 ± 0.87

0.636

-9.29 ± 1.14

0.127

-32.9 ± 0.2

32.37 ± 0.46

0.568

-8.32 ± 0.82

0.172

-40.2 ±1.82

31.54 ± 0.21

0.497

-8.61 ±0.77

D

H
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ζ potential
(media)

Fig 17: Model design.
(a) Schematic (dimensions in cm) depicting the transwell insert in one well of a 24 well
plate with an inlet and an outlet tube connected to the peristaltic pump. (b) Actual image
of the 24 well plate with each well connected to the peristaltic pump via an inlet and an
outlet tube.
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Table 4: Characterization data for Au-NPs dispersed in media under static vs
dynamic conditions
*Hydrodynamic diameter (DH) dispersed in culture media, obtained using DLS. Poly
dispersity Index (PdI) was determined to assess uniformity in size distribution of AuNPs. The mean hydrodynamic diameters from three experiments were averaged and
represented as mean ± SEM.
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Table 4
Static
Nominal
diameter (nm)

Dynamic

D *
H

PdI

D *
H

PdI

5

50.17 ± 0.47

0.975±0.016

29.36 ± 0.303

0.709±0.073

10

31.85 ± 0.97

0.607±0.049

25.85 ± 0.215

0.510±0.010

30

37.57 ± 0.22

0.655±0.063

30.29 ± 0.22

0.508±0.003
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Fig 18. Intensity plots obtained using DLS for Au-NPs dispersed in media under
static vs dynamic conditions
Depicted are the intensity plots as generated by DLS for different sizes of Au-NPs (5, 10
and 30 nm) after 24 hr incubation under static vs dynamic conditions.

91

Fig. 18

92

We also observed a decrease in DH and increase in PdI for NP agglomerates under flow
conditions (Table 4; compare DH under static conditions to DH under dynamic
conditions). This decrease in size and dispersity was more evident for 5 nm as compared
to 10 nm Au-NPs and 30 nm NPs (Table 4). These results were further confirmed using
the intensity plots as generated by DLS where we saw an overall shift of the peaks toward
left suggesting lower size distribution of agglomerates under dynamic conditions.
Hoever, this shift wasn’t evident for 10 and 30 nm Au-NPs (Fig. 18). These changes can
be attributed to the shear experienced by NPs flowing under dynamic conditions which
leads to erosion, resulting in a reduced and narrowed DH distribution. Erosion is
characterized by the detachment of small fragments from the outer surface of the
agglomerate under shear stress and increases with increasing shear until a minimum DH is
achieved (Kalra et al., 2010, Scurati et al., 2005). As reported previously, the
agglomerates are composed of a hard corona, consisting of a tightly bound NPs and
proteins, and a soft corona, consisting of more loosely bound NPs and proteins. The soft
corona is dynamically exchanged with the media as the agglomerate is transported to new
physiological environments (Lundqvist et al., 2008). Based on our observations, we
propose that the soft corona is easily removed in shear flow by erosion resulting in a
decrease in agglomerate size under dynamic conditions.
A more pronounced correlation between erosion and shear stress was observed
when we increased the flow rate from 1.5 mL/min to 6 mL/min (Fig. 19). The rationale
was to evaluate the effect of increased shear on the NP agglomerates using the maximum
flow rate allowable in our dynamic set-up. We reported individual peak agglomerate
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Fig 19: NP agglomerate size decreases under dynamic (flow) conditions.
(a) Schematic depicting erosion of NPs under flow conditions. NP agglomeration was
observed in complete culture media due to reduction of electrostatic repulsion and
adsorption of proteins/other media components. Under flow conditions, erosion removes
loosely bound NPs and/or proteins leaving compact agglomerates which can be observed
using DLS. (b) Comparison of agglomerate sizes of Au-NPs dispersed in complete
culture medium exposed to static, low flow (1.5mL/min) and high flow conditions
(6.0 mL/min). Au-NPs (5, 10 and 30 nm) were dispersed in complete culture medium at
a concentration of 5 μg/mL and exposed to static, low flow (1.5 mL/min) and high flow
(6 mL/min) conditions for 24 h. Samples were analyzed immediately after exposure using
DLS. Peaks identified by DLS were plotted for each NP sample. Results are
representative of 3 experiments.
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sizes generated by DLS to compare static (no flow), low flow rate (1.5 mL/min) and high
flow rate (6 mL/min) for each of the NP sizes. We observed a flow rate-dependent
decrease in the sizes of the agglomerates (Fig. 19b). Based on these results, the NP
agglomerate size of approximately 30 nm appears to be thermodynamically favorable for
all three sizes investigated. Overall, our results indicate that adding flow to NP dispersion
leads to decrease in size of agglomerates.
NP deposition in dynamic versus static conditions
We then proceeded to evaluate the deposition pattern of Au-NPs on aminosilanefunctionalized glass coverslips based on the inherent affinity of Au for amine group (NH2) (Ungureanu et al., 2010, Scarpettini and Bragas, 2010). The functionalized
coverslips were placed on the luminal side of the transwell membrane and exposed to NP
solutions (prepared in media at 5μg/mL). Based on the darkfield images, more NP
deposition was observed under static conditions compared to dynamic conditions for all
the Au-NP sizes tested (Fig. 20). However, since NPs less than 20 nm do not scatter light
very efficiently, this microscopy based technique to visualize NP deposition is very
qualitative in nature owing to the low resolution. Therefore, these deposition results were
further confirmed by quantification of Au-NPs deposited on the coverslips using ICP-MS
(Fig. 21). Under static conditions we observed high variability between different
experiments, especially for 10 nm Au-NPs (Fig. 21). Based on our DLS data we saw
largest aggregates for 5 nm Au-NPs under both static and dynamic conditions. Therefore,
it was assumed that since bigger agglomerates will have higher sedimentation, we would
observe higher deposition in case of 5 nm Au-NPs. Although, this assumption was true
for static condition, we saw different results for dynamic conditions where all three sizes
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had similar deposition. This discrepancy in the results could be because of the known
issues associated with DLS evaluation of polydisperse NP samples. Since NPs form nonuniform aggregates in physiological media, DLS is not appropriate to obtain the correct
dimensions of the materials as this method is standardized for only spherical
nanomaterials.
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Fig 20: Au-NPs deposition on aminosilane- functionalized coverslips in static vs
dynamic conditions.
Aminosilane-functionalized coverslips (5 mm) were placed on the luminal side of the
transwell membrane and treated with 5 µg/ml of 5, 10 or 30 nm Au-NPs for 24 hr with or
without flow of media. One representative darkfield image is depicted for each NP size
under static conditions and under dynamic conditions (b). Only aggregates >30 nm can be
visualized using darkfield imaging.
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Fig 21: Quantification of Au-NP deposition on aminosilane- functionalized
coverslips in static vs dynamic conditions.
Aminosilane-functionalized coverslips (5 mm) were placed on the luminal side of the
transwell membrane and treated with 5 µg/ml of 5, 10 or 30 nm Au-NPs for 24 hr without
(a) or with flow of media (b). Au-NP deposition on coverslips was then quantified using
ICP-MS. Mean ± SEM were generated from three separate experiments. * and **,
significant differences at p<0.05 or p<0.01 were determined by a 1-way ANOVA with a
Bonferroni's Multiple Comparison Test.
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Nanoparticle association with cells in dynamic versus static conditions in a single cell
culture
NP uptake in cells is usually governed by energy-dependent processes such as
endocytosis (Chithrani et al., 2006, Albanese and Chan, 2011). Therefore, acellular
conditions do not directly represent the bio-nano interaction. In order to qualitatively
evaluate the NP association with cells in static versus dynamic conditions we cultured
and treated astrocytes in upright position in the bottom of a 24 well plate with or without
flow for 24 h and analyzed the samples using darkfield imaging. More NPs were seen
associated with the cells in static conditions in comparison to dynamic conditions which
is similar to the trend that we observed in acellular conditions (Fig. 22). Since dose based
response is an integral part of toxicity studies and NP deposition on cells has a bearing on
uptake, the difference in NP association with the cells in static versus dynamic conditions
could have a significant impact on cell viability and function.
Nanoparticle association with cells in dynamic versus static conditions in a co-culture

To further evaluate the proposed model set-up, we utilized a co-culture of brain
endothelial cells and astrocytes. The model was designed keeping in mind some of the
key features of the ‘BBB’ such as continuous blood flow, a confluent and tight
monolayer of brain endothelial cells supported by the basement matrix and co-cultured
with astrocytes (Abbott et al., 2006). The morphology, monolayer growth and confluence
of endothelial cells on the membrane was assessed using TEM and fluorescence imaging
(Fig. 22). The TEERs of the mono- and co-culture set-ups grown on the transwells inserts
was recorded on the 8th day of culture.
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Fig 22: Visualization of Au-NPs associated with astrocytes in static vs dynamic
conditions.
Astrocytes at 2.8 × 104 cells/ well were cultured in a 24 well plate and treated with 5
g/mL of 5or10 nm Au-NPs for 24 hr with or without flow of media. After 24 hr the cells
were fixed for darkfield imaging. Experimental set-up is depicted (a). Four representative
images are depicted for each NP size used under static and under dynamic conditions (b).
Results are representative of two separate experiments.

103

Fig. 22

104

The co-culture had the highest TEER of 112.0 ± 2.6 Ωcm2, followed by the mono-culture
of endothelial cells, 94. 7 ± 3. 3 Ωcm2 and astrocyte monolayer had a TEER of 24.0 ± 3.7
Ωcm2 (Fig. 24a). Diffusive permeability for FITC-labeled dextran in the monoculture setup was very low in comparison to control (no cells) indicating a tight layer of endothelial
cells (Fig 24b). We did not observe any changes in TEER, permeability and morphology
of the cell culture after 24 h exposure to continuous flow of media (data not shown)
probably due to the low shear (0.0074 dynes/cm2) experienced by the cells as determined
by multi-physics software program Comsol (version 4.2a). This low shear stress is a
characteristic of regions where arteries and veins bifurcate in in vivo conditions (Lee et
al., 2010, Feaver et al., 2013).
This set-up was then exposed to static or continuous flow of media containing
different sizes of Au-NPs (5 nm, 10 nm or 30 nm) at 5 μg/mL for 24 h. Association of
NPs with the co-culture was then assessed using darkfield imaging. We observed
relatively more NPs associated with the cells in static versus the dynamic conditions (Fig.
25). Although the scattering from the pores in the transwells membrane interfered with
visualization of NPs, we could still distinguish the agglomerates of Au-NPs from the
background as they appeared yellow/red due to their surface plasmon property. We also
quantified the NP uptake by cells using ICP-MS, which correlated with the qualitative
observations i.e. cellular uptake was more in case of static conditions as compared to
dynamic conditions (Fig. 26). In the static condition, we observed more uptake in case of
5 nm and 10 nm Au-NPs in comparison to 30 nm Au-NPs which was similar to the trend
of deposition that we observed in acellular set-up. Surprizingly, we observed more uptake
for 10nm Au-NPs in comparison to 5 and 10 nm which did not correlate with the
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deposition pattern under acellular conditions. The difference in deposition and uptake
pattern under flow conditions, in acellular versus the co-culture set-up, might be because
of size-preferential uptake of NPs by the endothelial cells. However, this needs more
indepth analysis before further conclusions could be drawn. Overall, the cellular uptake
was higher for static versus dynamic conditions, and the cell uptake was more uniform
within the three NPs in dynamic conditions.
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Fig 23: bEnd.3 cells form a monolayer on Transwell® membrane.
C8-D30 cells at 2.8 × 104 cells/ membrane were seeded on the matrigel-coated abluminal
side of the transwell membrane. bEnd. 3 cells (1 × 105 cells/ml) were seeded on the
luminal side and cultured for 8 days. The cells were then fixed on the membrane and
either stained using actin (Red, AlexaFluor 555) and nuclear (Blue, Prolong gold antifade
with DAPI) stain for fluorescence imaging or prepared for TEM. Depicted here are
fluorescence images of bEnd.3 cells (a) and C8-D30 cells (b). TEM images with bEnd.3
cells on luminal side of the membrane and C8-D30 cells in matrigel are also depicted (c
and d).
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Fig 24: bEnd.3 cells form a tight barrier on Transwell® membrane.
C8-D30 cells at 2.8 × 104 cells/ membrane were seeded on the matrigel-coated abluminal
side of the transwell membrane. bEnd. 3 cells (1 × 105 cells/ml) were seeded on the
luminal side and cultured for 8 days. TEER for monoculture of C8-D30 and bEnd.3 cells
and that of co-culture was recorded (a). Paracellular permeabililty were assessed using
FITC-Tagged 40 Kd Dextran (b). Mean ± SEM were generated from three separate
experiments. ** and ***, Significant differences at p<0.05 or p<0.01 were determined by
a 1-way ANOVA with a Bonferroni's Multiple Comparison Test.

109

Fig. 24

110

Fig. 25: Visualization of Au-NPs associated with co-culture in static vs dynamic
conditions.
C8-D30 cells at 2.8 × 104 cells/ membrane were seeded on the matrigel-coated abluminal
side of the transwell membrane and bEnd. 3 cells (1× 105 cells/ml) were seeded on the
luminal side and cultured for 8 days. The co-culture was then treated with Au-NPs (5, 10
and 30 nm) for 24 hr with or without flow. The experimental set-up is depicted (a). After
24 hr, the membrane with cells were washed with 1× PBS and cut out from the
Transwells and fixed for dark field imaging
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Fig. 26: Quantification of Au-NPs taken up by the co-culture set-up in dynamic vs
static conditions.
C8-D30 cells at 2.8 × 104 cells/ membrane were seeded on the matrigel-coated abluminal
side of the transwell membrane and bEnd. 3 cells (1× 105 cells/ml) were seeded on the
luminal side and cultured for 8 days. The co-culture was then treated with Au-NPs (5, 10
and 30 nm) for 24 hr with or without flow. After 24 hr, the membrane with cells were
washed with 1× PBS and cut out from the Transwells and acid digested to quantify the
total Au concentrations in the cells (co-culture) using ICP-MS (c). Mean ± SEM were
generated from three separate experiments. * and **, Significant differences at p<0.05 or
p<0.01 were determined by a 1-way ANOVA with a Bonferroni's Multiple Comparison
Test.
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Impact of Au-NPs on astrocytic and endothelial cell function
Astrocytes and endothelial cells respond to a number of stimuli (neurotoxins,
antigens) by secreting cytokines and chemokines. NPs, including Au-NPs, have been
shown to cross the ‘BBB’ suggesting a potential exposure of astrocytes and endothelial
cells to these nanomaterials (Morais, 2012, De Jong et al., 2008). In order to evaluate the
impact of Au-NPs on our co-culture set-up, we co-cultured, C8-D30 cells with bEnd.3
cells and treated them with three different sizes of Au-NPs (5, 10 and 30 nm) under static
or dynamic conditions. After 24 hour treatment, the media from the bottom of the 24-well
plate was collected to evaluate change in levels of inflammatory cytokines secreted by
astrocytes and endothelial cells relative to untreated control using ELISA. No secretion
was observed for any of the cytokines except for IL-6, which has previously been shown
to be endogeneously secreted by C8-D30 cell line (An et al., 2011). We did not observe
any change in IL-6 levels in treated vs the untreated conditions under both dynamic and
static set-up suggesting no change in cell function in terms of the cytokines evaluated
(Fig. 27).
Taken together, our data demonstrates that adding flow to an in vitro model
reduces size of NP agglomerates consequently decreases sedimentation of NPs. We also
show that agglomeration and sedimentation are bigger issues for very small particles
(~5nm), presumably due to their high surface area to volume ratio which leads to
formation of bigger aggregates. Although the flow rate (1.5ml/min) utilized in this study
produced very low shear stress (0.0074dynes/cm2) we observed lower sedimentation and
cellular uptake for dynamic conditions compared to static conditions (Fig. 28). Using
computational modeling, previous studies have demonstrated that areas of very low shear
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stress (< 1dynes/ cm2), comparable to this study, exist around the bifurcations of arteries
and veins (Lee et al., 2010, Feaver et al., 2013). Since biomedical applications of Au-NPs
involve intravenous administration, these areas of low shear stress might be the potential
areas of NP uptake through the vascular endothelium. Furthermore, in vivo studies have
demonstrated localization of NPs in organs, such as spleen, liver, heart and kidneys. The
flow velocities of interstitial fluid in these organs can be in the range of 0.1-2.0 μm/, as
demonstrated previously (Polacheck et al., 2011, Chary and Jain, 1989, Dafni et al.,
2002) suggesting that the model set-up described in present study could be employed to
other cell models. Furthermore, we did not see any change in cell viability or function
after treatment with Au-NPs, which might imply that the concentration, shape and sizes
of Au-NPs utilized in this study do not produce overt toxicity in the astrocytic and
endothelial cell lines. However, future studies should be conducted in primary cell types
and in in vivo models to confirm the effects.
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Fig 27: Au-NPs do not impact endothelial or astrocytic cell function.
C8-D30 cells at 2.8 × 104 cells/ membrane were seeded on the matrigel-coated abluminal
side of the transwell membrane. bEnd. 3 cells (1 × 105 cells/ml) were seeded on the
luminal side and cultured for 8 days. The co-culture was then treated with three different
sizes of Au-NPs under static or dynamic conditions. After 24 hour treatment, the media
from the bottom of the 24-well plate was collected to evaluate change in levels of proinflammatory cytokines secreted by astrocytes and endothelial cells relative to untreated
control using ELISA. Mean ± SEM was generated from two separate experiments.
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Fig 28: Nanoparticle agglomeration and sedimentation under dynamic and static
conditions.
Depicted is the dynamic and static co-culture (endothelial cells and astrocytes) set-up
utilized in the study. NPs agglomerate in the biological media utilized in in vitro studies.
Agglomeration leads to sedimentation of NPs on the cell layer leading to increased
uptake. Adding flow to the in vitro model decreases sedimentation owing to uniform
dispersion of NP solution.
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V Chapter III: CONCLUSION
Since nanotechnology is a relatively new area of science, few studies have thoroughly
characterized the biological impact of Au-NPs or taken a mechanistic approach to study
biointeraction of NPs. Unfortunately, the mechanisms of toxicity seem to depend on
physiochemical properties of nanomaterials in conjunction to the cell type and the
treatment conditions used, making it impossible to generalize the impact of NPs.
Therefore, in this study we evaluated the impact of Au-NPs in three different cell types,
B-lymphocytes, endothelial cells and astrocytes, selected on the basis of being a direct or
indirect target to the intravenous administration of NPs. In addition to taking a
mechanistic approach to study the mode of action of Au-NPs, the strength of the study is
the simulation of static vs dynamic culturing conditions to reflect the in vivo
environment. Additionally, this study also led to development of a dynamic in vitro
model which is cost effective and will provide the capability to evaluate multiple
endpoints to study the physiological aspects of the ‘BBB’. Furthermore, thorough
characterization of Au-NPs before and after treatment of cells, in addition to evaluation
of aggregation patterns in static vs dynamic conditions will provide information on NP
behavior in vivo, which might help fill the gaps that exist in the field of nanotechnology
regarding the complex issue of NP aggregation in a biological environment. In
conclusion, we did not observe any change in cell viability or morphology in either of the
two model systems (B cells and BBB model), although we saw change in B-cell function
in terms of an increase antibody secretion but no change in astrocytic or endothelial cell
function. These data further strengthen the fact that the effect of NPs on cell systems
cannot be generalized and cell function could be altered even in the absence of overt
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toxicity Therefore, assessment of cell function should be a part of toxicological analysis
of these novel materials. We also demonstrated that adding flow to a NP solution
decreases the aggregate sizes and reduces sedimentation which might be physiologically
relevant as the cells experience fluid flow (interstitial fluid or blood flow) under in vivo
conditions. In the light of the issues that exist with NPs characterization using DLS, there
is a need to develop more techniques that accurately characterize NP behavior in
physiological conditions. Additionally, there is a need to develop in vitro models that are
closer to in vivo environment for toxicological evaluations to narrow the gap between the
in vitro and in vivo studies.
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VII. APPENDIX
LIST OF ABBREVIATIONS
AFM: Atomic Force Microscopy
Au-NPs: Gold Nanoparticles
BBB: Blood Brain Barrier
CNS: Central Nervous System
CTAB: Cetyltrimethylammonium Bromide
DLS: Dynamic Light Scattering
ELISA: Enzyme linked Immunosorbent Assay
Ig: Immunoglobulin
ICP-MS: .Inductively Coupled Plasma Mass Spectrometry
IL: Interleukin
IKK: Inhibitor of nuclear factor κB kinase
LPS: Lipopolysaccharide
NF-κB: Nuclear factor κ-light-chain-enhancer of activated B cells
PEG: Polyethylene Glycol
ROS: Reactive Oxygen Species
TEM: Transmission Electron Microscopy
UV-Vis: Ultra-Violet Visible Spectroscopy
3’IghRR: 3’Ig Heavy chain regulatory region
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